Hemant surgical Industries zooms on inking pact with GBT Korea
The agreement aims to develop and localize x-ray generators, electronic control systems and c-arm imaging device utilizing fluoroscopy x-ray technology
Hemant surgical Industries is currently trading at Rs. 266.25, up by 11.60 points or 4.56% from its previous closing of Rs. 254.65 on the BSE.
The scrip opened at Rs. 247.50 and has touched a high and low of Rs. 283.00 and Rs. 231.10 respectively. So far 27600 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 367.10 on 18-Sep-2025 and a 52 week low of Rs. 89.99 on 05-Jun-2025.
Last one week high and low of the scrip stood at Rs. 283.00 and Rs. 215.00 respectively. The current market cap of the company is Rs. 355.95 crore.
The promoters holding in the company stood at 58.90%, while Institutions and Non-Institutions held 10.96% and 30.14% respectively.
Hemant surgical Industries has entered into a C-ARM Development and Supply Agreement with GBT Korea Co., Republic of Korea to collaborate with their strong technological expertise to develop and localize x-ray generators, electronic control systems and c-arm imaging device utilizing fluoroscopy x-ray technology to provide real time high resolution imaging during surgical orthopaedic, trauma and cardio vascular procedures.
Hemant surgical Industries is engaged in the business of manufacturing, importing, assembly and marketing of medical equipment and disposables.

